Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POTENT: Tipranavir vs Darunavir in Treatment-Experienced HIV
NCT00517192Phase 3Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2007
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of tipranavir in human immunodeficiency virus infection (HIV), sponsored by Boehringer Ingelheim. Started Sep 2007; status: terminated.
02
Drugs
tipranavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00517192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00517192.